Table 2.
Prevalence of phenotypic ESBL-producing isolates by combined disc diffusion test.
| Combined antibiotic discs | Bacterial isolates (n = 100) | ||||
|---|---|---|---|---|---|
| K. oxytoca (n = 15) | K. pneumoniae (n = 36) | E. coli (n = 44) | P. mirabilis (n = 5) | n (%) | |
| Ceftazidime | 10 (66.7%) | 29 (80.6%) | 36 (86.4%) | 4 (80.0%) | 79 (79%) |
| Cefotaxime | 11 (73.3%) | 35 (97.2%) | 43 (97.7%) | 5 (100%) | 94 (94%) |
| Cefpodoxime | 15 (100%) | 33 (91.7%) | 39 (88.6%) | 4 (80.0%) | 91 (91%) |
| Ceftriaxone | 15 (100%) | 35 (97.2%) | 39 (100%) | 2 (40%) | 91 (91%) |
| Mean (n = 89) | 13 (87%) | 33 (92%) | 39 (87%) | 4 (80%) | 89 (89%) |